ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,952.18
1.45%
Dow Jones
42,994.97
1.54%
US Dollar vs MXN
20.09645
-1.24%
Brent Oil
72.835
0.62%
Bitcoin
96,733.12
-0.75%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Vivos Inc (QB) (RDGL) Cotización

Vivos Inc (QB)

Vivos Inc (QB) (RDGL)

USOTC
0.0874
0.0074
( 9.25% )
Actualizado: 11:37:52
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.0874
Postura de Compra
0.0836
Postura de Venta
0.0878
Volume Operado de la Acción
359,543
0.082 Rango del Día 0.0878
0.049 Rango de 52 semanas 0.255
Capitalización de Mercado [m]
36.498M
Precio Anterior
0.08
Precio de Apertura
0.082
Hora
10844
@
0.0874
Última hora de negociación
11:37:37
Volumen financiero
US$ 30,488
Precio Promedio Ponderado
0.084796
Volumen promedio (3 m)
1,035,969
Acciones en circulación
417,592,703
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-13.04
Beneficio por acción (BPA)
-0.01
turnover
20k
Beneficio neto
-2.9M

Acerca de Vivos Inc (QB)

Vivos Inc, developed an yttrium-90 brachytherapy device to combat cancer in humans and animals. Testing at Washington State University, the University of Missouri and our pilot veterinary clinic has verified the safety to the patient, the therapist and the family members. IsoPet is commercially avai... Vivos Inc, developed an yttrium-90 brachytherapy device to combat cancer in humans and animals. Testing at Washington State University, the University of Missouri and our pilot veterinary clinic has verified the safety to the patient, the therapist and the family members. IsoPet is commercially available for animal therapy and can deliver very high doses to solid tumors with a single same day therapy. Pre-clinical testing is in progress to generate key data for an Investigational Devise Exemption to the FDA to begin human clinical trials. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
www.radiogel.com
Sede
Wilmington, Delaware, USA
Fundado
-
Vivos Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker RDGL. The last closing price for Vivos (QB) was US$0.08. Over the last year, Vivos (QB) shares have traded in a share price range of US$ 0.049 to US$ 0.255.

Vivos (QB) currently has 417,592,703 shares in issue. The market capitalisation of Vivos (QB) is US$33.41 million. Vivos (QB) has a price to earnings ratio (PE ratio) of -13.04.

RDGL Últimas noticias

Más noticias

Form 253G2 -

18 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Noviembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

28 Octubre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

30 Septiembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Agosto 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Agosto 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Agosto 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

02 Agosto 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

29 Julio 2024
Edgar (US Regulatory)

Form QUALIF - Notice of Qualification [Regulation A]

16 Julio 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.00647.90123456790.0810.08780.061113111010.07601373CS
4-0.0011-1.242937853110.08850.0970.061110577030.08243293CS
12-0.0796-47.66467065870.1670.180.061110359690.11076432CS
26-0.1311-600.21850.2550.061113568240.13360025CS
520.034966.47619047620.05250.2550.04912738480.13160798CS
1560.012316.37816245010.07510.2550.047522430.10224444CS
2600.04765119.8742138360.039750.310.013510699470.10147462CS

RDGL - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Vivos (QB)?
El precio actual de las acciones de Vivos (QB) es US$ 0.0874
¿Cuántas acciones de Vivos (QB) están en circulación?
Vivos (QB) tiene 417,592,703 acciones en circulación
¿Cuál es la capitalización de mercado de Vivos (QB)?
La capitalización de mercado de Vivos (QB) es USD 33.41M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Vivos (QB)?
Vivos (QB) ha negociado en un rango de US$ 0.049 a US$ 0.255 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Vivos (QB)?
El ratio precio/beneficio de Vivos (QB) es -13.04
¿Cuál es la moneda de reporte de Vivos (QB)?
Vivos (QB) presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Vivos (QB)?
El último ingresos anual de Vivos (QB) es USD 20k
¿Cuál es el último beneficio anual de Vivos (QB)?
El último beneficio anual de Vivos (QB) es USD -2.9M
¿Cuál es la dirección registrada de Vivos (QB)?
La dirección registrada de Vivos (QB) es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Vivos (QB)?
La dirección del sitio web de Vivos (QB) es www.radiogel.com
¿En qué sector industrial opera Vivos (QB)?
Vivos (QB) opera en el sector SURGICAL,MED INSTR,APPARATUS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.10
(99,900.00%)
100
GNTLFGenetic Technologies Ltd (PK)
US$ 1.00
(90,809.09%)
100
VIVEViveve Medical Inc (CE)
US$ 0.0003
(29,900.00%)
7.33k
BTIMBoatim Inc (CE)
US$ 0.0002
(19,900.00%)
799
CLVRClever Leaves Holdings Inc (CE)
US$ 0.0002
(19,900.00%)
590
RAASYCloopen Group Holding Limited (CE)
US$ 0.000001
(-100.00%)
204
EWGFFEat Well Investment Group Inc (CE)
US$ 0.000001
(-100.00%)
47.01k
AGDXFAntioqua Gold Inc (CE)
US$ 0.000001
(-99.99%)
102k
SOLBFSoLVBL Solutions Inc (CE)
US$ 0.000001
(-99.99%)
10k
NMRDNemaura Medical Inc (CE)
US$ 0.000001
(-99.50%)
3.6k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
302.27M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.0001
(0.00%)
215.58M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
125.21M
RDARRaadr Inc (PK)
US$ 0.0015
(25.00%)
100.71M
CHNVFChina Youzan Ltd (PK)
US$ 0.0177
(10.63%)
100M

RDGL Discussion

Ver más
konshe konshe 3 horas hace
This oversold and undervalued stock now is going up. Uptrend is confirmed. Next week it will break out 0.10 for sure. RDGL is a best stock to own on 2025.
👍 3
FatFatCat FatFatCat 3 horas hace
Nice volume this morning.

To those arguing with idiots, remember this:

“Never argue with an idiot. They will drag you down to their level and beat you with experience.”
-- Mark Twain
👍 3
chereb19 chereb19 3 horas hace
Your inability to say they lied in a SEC filing tells us all we need to know.

You must love the Doc and be proud he managed to get a BDD
👍️0
Truthsocial Truthsocial 3 horas hace
Is your garbage company doing as well as these garbage companies....asking for RDGL CEO Dr Korenko

https://www.zippia.com/advice/largest-waste-management-companies/
👍️0
SC8 SC8 3 horas hace
The only source for the BDD claim is MK,, a proven serial liar. But it doesn't matter now whether true or not. Time has proven the "news" was of no consequence towards getting Radiogel to market.
👍️0
Rum_Tequila Rum_Tequila 4 horas hace
it must be so gratifying for you to make a (paltry) living attempting to dupe the most low IQ of investors with your idiotic claims… no independent verification? it was NEWS
👍️0
chereb19 chereb19 4 horas hace
It's on there SEC filings.

You won't say they are lying there so one can only conclude you believe it's been granted.
👍️0
chereb19 chereb19 4 horas hace
Not my fault you can't read a 10-q

Isopet is profitable.
👍️0
SC8 SC8 4 horas hace
If FDA awarded BDD to Radiogel (there's been no independent corroboration to serial liar MK's claim), it's year old news now and has proven to be of no consequence. To date MK hasn't even bothered to ask FDA for human trial authorization. They told him years ago what they need and he either can't or won't deliver. Those are the known facts.
👍️0
SC8 SC8 4 horas hace
Sorry, but there is no plausible scenario of RDGL surviving without getting Radiogel to market. Every $ and every minute that MK spends on hopeless IsoPet is a $ and a minute robbed from the only thing that matters. It's just another example of his gross incompetence.
👍️0
Truthsocial Truthsocial 5 horas hace
You really should invest in a garbage company because alone you would be their biggest customer without a doubt...

Expansion of many more veterinarian locations treatments with Isopet can be very profitable everyone knows this except Elmer's glue stick...
And do you really believe these veterinarians are paying attention to
Mr Elmer's glue stick lol
No they have done their due diligence I'm sure.
Wow what a loser Elmer Fudd is
Many companies also operate at a loss on paper but are valued in the billions.
Not Sounding to intelligent just a useless distraction skat....

RDGL MAYO CLINIC AND ISOPET LEADING THE WAY

To eliminate cancer with outpatient treatment

On another note
👍️0
chereb19 chereb19 5 horas hace
The SEC filings don't lie. Isopet made a profit.

Isopet and Radiogel are in a class of their own. They have a breakthrough device designation from the FDA proving they have no competition.
👍️0
chereb19 chereb19 5 horas hace
Whopper of a lie
You really can't be trusted
👍️0
SC8 SC8 6 horas hace
RDGL's financials say otherwise. Most IsoPet treatments are sold at a loss. There is no plausible scenario of RDGL becoming profitable via IsoPet no matter how long MK extends runway via dilution. IsoPet is a sad distraction for what now? 6 years?
👍️0
SC8 SC8 6 horas hace
Already asked and answered. Read the quarterly financials. It's all there. Most if not all IsoPet treatments are sold at a loss. Many one can cherry pick some profitable IsoPet treatments but there's no plausible scenario of RDGL even getting close to covering their overhead via IsoPet treatments no matter how long someone extends the runway via dilution. Those facts are what makes IsoPet a hopeless distraction being done at the expense of only thing that matters: getting Radiogel to market.

RDGL is an FDA play, nothing more, and MK has proven completely incompetent dealing with FDA.
👍️0
chereb19 chereb19 7 horas hace
Read the last 10-Q
👍️0
rogers711 rogers711 7 horas hace
That's also not true... 😂 where? 
👍️0
chereb19 chereb19 11 horas hace
Isopet has been proven to be profitable
👍️0
rickstereo3333 rickstereo3333 14 horas hace
Could someone kindly create a "GLUE" Board so this Muppet eejit can saunter over and debate himself..........SC8sceeate???

TIA
👍 1
rickstereo3333 rickstereo3333 14 horas hace
All pointless if it fails and based on what i've seen.......its sticky shite!
👍 1
Shanesland Shanesland 17 horas hace
Complete idiot... Nobody here wants the glue….
👍️ 2
rogers711 rogers711 17 horas hace
Nobody was talking about overhead... isopet, you claim you know they are selling it for a loss... how?
👍️ 1
SC8 SC8 18 horas hace
RDGL overhead is at minimum ~$2.5 million/year. That's what they need from IsoPet just to break even. Even if IsoPet was profitable, there's no plausible path to get the needed volume. But so far IsoPet isn't profitable. Most all IsoPet treatments are sold below cost. The situation is hopeless. Only thing that matters now is getting Radiogel to market and MK has proven completely incapable of doing so.
👍️0
WhAtEvA1 WhAtEvA1 19 horas hace
Poor 👉AtlasQ and mc73 salivating for 0.05, LOL!
👍️0
SC8 SC8 19 horas hace
Just look are last couple years or more of RDGL quarterly financials. IsoPet is a hopeless distraction.
👍️0
SC8 SC8 19 horas hace
If Doc Fisher is so great, why did he set back RDGL many years by failing to verify Radiogel containment in rabbit tumors within the critical 10 day period after treatment? He screwed up so bad the work had to be repeated at JHU Vet School. Doc Fisher is just another gross incompetent.
👍️0
rogers711 rogers711 19 horas hace
That's not how profit works bud 😂😂 it's impossible to break even and profit 2.5 million 
👍️0
SC8 SC8 19 horas hace
So why isn't IsoPet even close to making RDGL profitable? It was launched what, 6 years ago? Why did it never take off, even when sold below cost? IsoPet is hopelessly unprofitable. Facts are facts
👍️0
SC8 SC8 19 horas hace
Read the financials. Most all IsoPet treatments are sold below cost. Moreover, IsoPet would have to yield $2.5 million/year just for RDGL to break even. That's not $2.5 million in revenue, but $2.5 million in profit just for RDGL to break even. There is no plausible path for RDGL to become profitable via IsoPet. It's just a sad distraction that MK is running at the expense of only thing that can save RDGL: getting Radiogel to market. To date, MK hasn't even bothered to ask FDA for authorization for human trials. He failed to get Radiogel to market before the original patents expired. In the meantime RDGL's competition has moved ahead into clinical trials.

Not my fault MK is a gross incompetent. Situation is what it is. I just cite the facts and draw obvious conclusions.
👍️0
konshe konshe 21 horas hace
RDGL great green chart, buy buy buy,run run run 2025 best stock.

https://www.stockscores.com/charts/charts/?ticker=rdgl
👍️0
rogers711 rogers711 1 día hace
Can you provide where cost vs profit is on isopet? I haven't found that info. 
👍️0
doccjc doccjc 1 día hace
Many care what the competent Dr Fisher thinks.
I'd listen more to what Dr Fisher has to say over someone pumping a glue company on a public message board.
Facts are facts and the lights will be coming on soon enough.
👍️ 1
Bigfootbud Bigfootbud 1 día hace
The global veterinary oncology market size was estimated at USD 1.57 billion in 2024 and is projected to grow at a CAGR of 12.08% from 2025 to 2030. Key growth drivers include increasing the prevalence of cancer in pets, increasing R&D in pet cancer therapy, and growing focus on animal safety. As per The Veterinary Cancer Society, cancer is the top reason of death in 47% of canines, particularly those over 10 years old, and in 32% of felines. In addition, around 1 in 4 dogs will experience abnormal tissue growth or neoplasia during their lifetime.

https://www.grandviewresearch.com/industry-analysis/veterinary-oncology-market
👍️ 1
Elonlies Elonlies 1 día hace
I strongly disagree SC8

Dr. Korenko is a very competent and RDGL has a bright future. Many lives will be saved!! The best is yet to come. GO RDGL!!
👍️0
Truthsocial Truthsocial 1 día hace
Prove your lies .....please without schuitt

When the ISOPET and RDGL treatments start increasing in volume they will easily become profitable this outpatient treatment is just beginning to become more mainstream watch and listen ...
Beginning of the new year announcements will prove you a fake...
Many more veterinarians coming on board
Then we have worldwide human clinical trials beginning imo
Try pounding sand with your d....
GO pedal your gluestick elsewhere
👍️0
1hunglo 1hunglo 1 día hace
I wholeheartedly believe in the Science but not the Scientist > No GO Korenko.
RDGL desperately needs a new capable CEO. In anyones intelligent opinion of the facts.
ANOTHER YEAR WASTED BY NGK & HIS HUGE EGO. SO SAD.
WHEN THERE ARE MANY LIVES THAT COULD HAVE BEEN SAVED IN THE PAST YEARS.
👍️ 1
chereb19 chereb19 1 día hace
What a whopper of a lie

https://isopet.com/
👍️0
SC8 SC8 1 día hace
Doesn't matter if there's demand for IsoPet or not when it's sold below cost. IsoPet would have to yield at least $2.5 million profit just for RDGL to break even. There's no plausible path to get there. It's a distraction. RDGL is an FDA play, nothing more, and MK has proven inept dealing with FDA.
👍️0
chereb19 chereb19 1 día hace
Still can't bring yourself to say they lied in SEC filings. Point is, your continued silence is an endorsement for the doc and Vivos

24/7
👍️0
SC8 SC8 1 día hace
Not my job to parse MK's lies from truth. Just saying MK is a confirmed serial liar and no reasonable person should believe anything he says. Regarding BDD, the point is moot either way. It's year old news now and has had no impact getting Radiogel to human trials.
👍️0
AtlasQ AtlasQ 1 día hace
Please humor me and tell me what did you figure out about me. 
👍️0
SC8 SC8 1 día hace
IsoPet has no plausible path to profitability. It's been a distraction for years done at expense of getting Radiogel to market. Just another example of MK's gross incompetence.
👍️0
SC8 SC8 1 día hace
Who cares what incompetent Dr. Fisher thinks (the guy who failed to do PET scans on rabbits within the critical ten days after Radiogel application to verify containment). He's the reason the rabbit testing had to be repeated by competent people at JHU Vet school!

Fact is YntraDose is in clinical trials and Radiogel isn't. Incompetent Dr. Fisher's opinion doesn't change that fact.

Facts are facts.
👍️ 1
rogers711 rogers711 1 día hace
If you are spending money expanding something not in demand it could be...
👍️0
lovethatgreen lovethatgreen 1 día hace
Don't need to be to figure you out
👍️0
lovethatgreen lovethatgreen 1 día hace
You've been a flip flop idiot right from the get go
👍️0
Truthsocial Truthsocial 1 día hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175547124
👍️0
chereb19 chereb19 1 día hace
Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy the designation as a Breakthrough Device pursuant to the FDA’s Breakthrough Devices Program.

👍️0
chereb19 chereb19 1 día hace
Still can't bring yourself to say they lied in SEC filings. Point is, your continued silence is an endorsement for the doc and Vivos

24/7

👍️0
Bigfootbud Bigfootbud 2 días hace
expansion is not a negative. ♥
👍️0

Su Consulta Reciente

USOTC
RDGL
Vivos (QB)
BIT
I09021
Intesa Sanpaolo
NASDAQ
EMEQ
Macquarie Focused Emergi...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados